142 related articles for article (PubMed ID: 7981016)
1. Formation and elimination of sulphamethoxazole hydroxylamine after oral administration of sulphamethoxazole.
van der Ven AJ; Mantel MA; Vree TB; Koopmans PP; van der Meer JW
Br J Clin Pharmacol; 1994 Aug; 38(2):147-50. PubMed ID: 7981016
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of sulphamethoxazole in man: effects of urinary pH and urine flow on metabolism and renal excretion of sulphamethoxazole and its metabolite N4-acetylsulphamethoxazole.
Vree TB; Hekster YA; Baars AM; Damsma JE; van der Kleijn E
Clin Pharmacokinet; 1978; 3(4):319-29. PubMed ID: 28128
[TBL] [Abstract][Full Text] [Related]
3. Sulphamethoxazole acetylation in fast and slow acetylators.
Bozkurt A; Basci NE; Isimer A; Tuncer M; Erdal R; Kayaalp SO
Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):164-6. PubMed ID: 2338369
[TBL] [Abstract][Full Text] [Related]
4. Urinary recovery and kinetics of sulphamethoxazole and its metabolites in HIV-seropositive patients and healthy volunteers after a single oral dose of sulphamethoxazole.
van der Ven AJ; Vree TB; van Ewijk-Beneken Kolmer EW; Koopmans PP; van der Meer JW
Br J Clin Pharmacol; 1995 Jun; 39(6):621-5. PubMed ID: 7654479
[TBL] [Abstract][Full Text] [Related]
5. Renal excretion of sulphamethoxazole and its metabolite N4-acetylsulphamethoxazole in patients with impaired kidney function.
Vree TB; Hekster YA; Damsma JE; van Dalen R; Hafkenscheid JC; Friesen WT
Ther Drug Monit; 1981; 3(2):129-35. PubMed ID: 7268825
[TBL] [Abstract][Full Text] [Related]
6. [Skin penetration of sulfamethoxazole and trimethoprim after oral administration].
Królicki A
Ann Acad Med Stetin; 2002; 48():59-73. PubMed ID: 14601469
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous determination of trimethoprim, sulphamethoxazole and N4-acetylsulphamethoxazole in serum and urine by high-performance liquid chromatography.
Gochin R; Kanfer I; Haigh JM
J Chromatogr; 1981 Apr; 223(1):139-45. PubMed ID: 7251755
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of sulphamethoxazole in calves and cows.
Nouws JF; Vree TB; Degen M; Mevius D
Vet Q; 1991 Jan; 13(1):10-5. PubMed ID: 2021049
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, acetylation-deacetylation, renal clearance, and protein binding of sulphamerazine, N4-acetylsulphamerazine, and N4-trideuteroacetylsulphamerazine in 'fast' and 'slow' acetylators.
Vree TB; Hekster CA; Baakman M; Janssen T; Oosterbaan M; Termond E; Tijhuis M
Biopharm Drug Dispos; 1983; 4(3):271-91. PubMed ID: 6626702
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics, metabolism and renal excretion of sulfatroxazole and its 5-hydroxy- and N4-acetyl-metabolites in man.
Vree TB; Hekster YA; Tijhuis MW; Termond EF; Nouws JF
Biopharm Drug Dispos; 1986; 7(3):239-52. PubMed ID: 3730524
[TBL] [Abstract][Full Text] [Related]
11. Placental transfer and renal clearance of sulphamethoxazole and its metabolite N4-acetylsulphamethoxazole in a pregnant ewe.
Vree TB; Reekers-Ketting JJ; Nouws JF; Arts TH
J Vet Pharmacol Ther; 1983 Mar; 6(1):77-81. PubMed ID: 6854735
[TBL] [Abstract][Full Text] [Related]
12. The effect of fluconazole and ketoconazole on the metabolism of sulphamethoxazole.
Gill HJ; Maggs JL; Madden S; Pirmohamed M; Park BK
Br J Clin Pharmacol; 1996 Sep; 42(3):347-53. PubMed ID: 8877026
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of sulphamethoxazole and trimethoprim administered intravenously and orally to Japanese quails.
Lashev LD; Mihailov R
J Vet Pharmacol Ther; 1994 Oct; 17(5):327-30. PubMed ID: 7853455
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of N1-acetyl- and N4-acetylsulphamethoxazole in man.
Vree TB; Hekster YA; Damsma JE; van der Kleijn E; O'Reilly WJ
Clin Pharmacokinet; 1979; 4(4):310-9. PubMed ID: 487686
[TBL] [Abstract][Full Text] [Related]
15. Determination of trimethoprim, sulphamethoxazole and its N4-acetyl metabolite in biological fluids by high-performance liquid chromatography.
Spreux-Varoquaux O; Chapalain JP; Cordonnier P; Advenier C; Pays M; Lamine L
J Chromatogr; 1983 May; 274():187-99. PubMed ID: 6603465
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, metabolism and renal clearance of sulphatroxazole in calves and cows.
Nouws JF; Vree TB; Mevius D; Degen M
J Vet Pharmacol Ther; 1989 Mar; 12(1):50-7. PubMed ID: 2704062
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and adverse effects of 20-mg/kg/day trimethoprim and 100-mg/kg/day sulfamethoxazole in healthy adult subjects.
Stevens RC; Laizure SC; Williams CL; Stein DS
Antimicrob Agents Chemother; 1991 Sep; 35(9):1884-90. PubMed ID: 1952863
[TBL] [Abstract][Full Text] [Related]
18. Kinetic disposition, systemic bioavailability, tissue levels and acetylation of some sulphonamides in goats.
Atef M; Youssef SA; Ramadan A; Issa M
Arch Int Pharmacodyn Ther; 1989; 302():27-39. PubMed ID: 2636822
[TBL] [Abstract][Full Text] [Related]
19. Excretion rates of sulfamethoxazole and N4-acetyl-sulfamethoxazole by fresh water turtles Pseudemys scripta elegans.
Vree TB; Vree JB
Vet Q; 1984 Jul; 6(3):169-73. PubMed ID: 6485242
[TBL] [Abstract][Full Text] [Related]
20. Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo.
Naisbitt DJ; Gordon SF; Pirmohamed M; Burkhart C; Cribb AE; Pichler WJ; Park BK
Br J Pharmacol; 2001 May; 133(2):295-305. PubMed ID: 11350866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
